Tony Liu is CEO & CFO at Cellular Biomedicine Group, Inc. (CBMG). They have made 7 open-market trades across 2 companies since 2007, most recently 2021-02-19.
CIK 0001378624
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $1.4M since 2007, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CBMG | BUY | 2017-12-22 | 2017-12-27 | $12.00 | $350K | +93.5% | +92.6% | +73.1% |
| CBMG | BUY | 2017-06-06 | 2017-06-07 | $6.83 | $68K | +4.3% | +27.0% | +48.2% |
| CBMG | BUY | 2014-05-22 | 2014-05-30 | $5.00 | $500K | -33.2% | -3.5% | -3.5% |
| CBMG | BUY | 2013-04-16 | 2013-04-17 | $5.00 | $4K | -33.2% | -3.5% | -3.5% |
| AOB | BUY | 2007-03-15 | 2007-03-16 | $9.45 | $189K | N/A | N/A | N/A |
| AOB | BUY | 2007-03-14 | 2007-03-15 | $8.67 | $260K | N/A | N/A | N/A |
| AOB | SELL | 2007-01-08 | 2007-01-10 | $12.10 | $12.1M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.